These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26855155)

  • 21. Kidney complications in 107 Fanconi anemia patients submitted to hematopoietic cell transplantation.
    da Cunha MM; Barreto FC; Nichele S; Trennepohl J; Ribeiro L; Loth G; Koliski A; de Almeida Pinto Jardim T; Mello A; Pasquini R; de Castro Sylvestre L; Bonfim C
    Eur J Pediatr; 2022 Feb; 181(2):715-723. PubMed ID: 34553252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival.
    Lopes JA; Gonçalves S; Jorge S; Raimundo M; Resende L; Lourenço F; Lacerda JF; Martins C; do Carmo JA; Lacerda JM; Prata MM
    Bone Marrow Transplant; 2008 Nov; 42(9):619-26. PubMed ID: 18622411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
    Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
    J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute renal failure after hematopoietic stem cell transplantation-review].
    Liu H; Liu BC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1118-22. PubMed ID: 19698273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation.
    Bauer A; Carlin K; Schwartz SM; Srikanthan M; Thakar M; Burroughs LM; Smith J; Hingorani S; Menon S
    Pediatr Nephrol; 2023 Apr; 38(4):1365-1372. PubMed ID: 36125547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4).
    Patel P; Sweiss K; Nimmagadda S; Gao W; Rondelli D
    Bone Marrow Transplant; 2011 Oct; 46(10):1326-30. PubMed ID: 21132027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
    Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant.
    Parikh CR; McSweeney P; Schrier RW
    Kidney Int; 2005 May; 67(5):1999-2005. PubMed ID: 15840050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney Injury in Children after Hematopoietic Stem Cell Transplant.
    James V; Angelo J; Elbahlawan L
    Curr Oncol; 2023 Mar; 30(3):3329-3343. PubMed ID: 36975466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
    Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.
    Aldenhoven M; Jones SA; Bonney D; Borrill RE; Coussons M; Mercer J; Bierings MB; Versluys B; van Hasselt PM; Wijburg FA; van der Ploeg AT; Wynn RF; Boelens JJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1106-9. PubMed ID: 25708213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A retrospective study of kidney insufficiency in adult patients after myeloablative allogeneic hematopoietic stem cell transplantation].
    Luo CW; DU X; Weng JY; Wu SJ; Guo R; Lu ZS; Ling W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):671-5. PubMed ID: 22739180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus.
    Raina R; Abu-Arja R; Sethi S; Dua R; Chakraborty R; Dibb JT; Basu RK; Bissler J; Felix MB; Brophy P; Bunchman T; Alhasan K; Haffner D; Kim YH; Licht C; McCulloch M; Menon S; Onder AM; Khooblall P; Khooblall A; Polishchuk V; Rangarajan H; Sultana A; Kashtan C
    Pediatr Nephrol; 2022 Jun; 37(6):1179-1203. PubMed ID: 35224659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome predictors of allogeneic hematopoietic stem cell transplant.
    Yang WC; Chen YT; Chang WW; Chang CH; Fan PC; Lee SY; Kao KC; Tian YC; Hung CC; Fang JT; Yang CW; Chen YC; Wang PN
    Am J Med Sci; 2013 Jan; 345(1):33-8. PubMed ID: 22475735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of acute kidney injury in children undergoing allogenic hematopoietic stem cell transplantation: A pilot study.
    Augustynowicz M; Kałwak K; Zwolińska D; Musiał K
    Adv Clin Exp Med; 2021 Jan; 30(1):87-92. PubMed ID: 33529512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.